People news: Boston Scientific and Elan

Share this article:
Boston Scientific named J&J devices chief Michael Mahoney president and, eventually, CEO. Mahoney joins from J&J, where he was worldwide chairman of the Medical Device and Diagnostics Group. He will replace Ray Elliott in those roles, though Cardiology, Rhythm and Vascular Group head Hank Kucheman will serve as interim CEO until November 1, 2012 when Mahoney assumes that role.

Elan named former FDA commissioner Andrew von Eschenbach, MD to its board of directors, along with former Biogen Idec exec Hans Peter Hasler (currently chairman of HBM Bioventures AG and principal of HPH Management GmbH). The Dublin-based company's executive director, Shane Cooke, has stepped down from the board but will stay on with the firm past its planned merger with Alkermes as president.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media